Boston Strategic Partners
Statistical and Econometric Analysis with ML/AI to support Innovation in Healthcare

Founded in 2003, Boston Strategic Partners (BSP) is a global advisory firm dedicated to the healthcare and life sciences industry. It offers five different services: business and clinical strategy, health economics & outcomes research (HEOR), medical communications, regulatory strategy, and financial advisory.

BSP believes that health economics influences decision-making at all levels of health care, and as a result, impacts critical business and clinical choices. The team at Boston Strategic Partners enables clients to establish relevant value to stakeholders (including payers, physicians, pharmacists, and hospital purchasers) from both a clinical and hard-numbers perspective, creating meaningful results. Additionally, these models and outputs are presented to end users through effective interfaces such as an app or other web-based functions.

“BSP has a strong clinical focus on demonstrating value. Our team comprises seven MDs, four PharmDs, over a dozen PhDs, and professionals with advanced qualifications across various aspects of healthcare, which combined with our 19 years of experience, delivers highly effective solutions,” says Fabian D’Souza, President and founder, BSP. “We are highly responsive to our clients, which makes us a trusted partner.”

BSP’s HEOR practice is supported by multiple real-world clinical and cost data from sources, such as the U.S. electronic health record (EHR) database spanning 20 years and encompassing over 100 million lives and 1.6 billion encounters.

Consequently, the company can run detailed studies with big data to provide tangible insights into the impacts of adopting a particular product.

What enables BSP to maintain its leadership position in the market is its commitment to excellence combined with a strong focus on putting clients first. Over 90% of revenues come from existing clients, and 95% of all clients hire us repeatedly. Most team members serve on review panels of peer-reviewed journals and international associations. They utilize their detailed clinical and health economic knowledge base and extensive publication experience to help clients achieve their goals.

The team has enabled BSP to serve clients across the pharmaceutical, medical device, and diagnostics industries since its inception. One of their success stories involves a client who introduced a new drug that could significantly help patients deal with cognition problems. Measuring cognition daily, however using traditional methods can be cumbersome. The firm recommended ways to improve measurement, helping the client showcase how their drug therapy was better at improving cognition, when compared to existing treatment options.

Instances of client success like this give BSP the impetus to explore new avenues of growth. The company has already made significant investments in cutting-edge AI/ML technologies to predict imminent requirements in the healthcare arena. Going forward, BSP will continue to embrace new innovations in healthcare so that they always provide clients with industry-leading results.